CORONAVIRUS/Adimmune gets green light to start human trials of COVID-19 vaccine
08/20/2020 05:49 PM
Taipei, Aug. 20 (CNA) An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given the green light to start human trials, making it the first in the country to receive approval, Taiwan's Food and Drug Administration (FDA) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![Taiwan reports 39,646 new COVID-19 cases, 134 deaths]()
Taiwan reports 39,646 new COVID-19 cases, 134 deathsTaiwan reported 39,646 new COVID-19 cases on Sunday, all but 60 domestically transmitted, and 134 deaths from the disease.06/26/2022 03:25 PM![Taiwan reports over 100 COVID-19 deaths for 25th consecutive day]()
Taiwan reports over 100 COVID-19 deaths for 25th consecutive dayTaiwan on Saturday reported 40,398 new COVID-19 infections and 151 deaths from the disease, the 25th day in a row that it has had over 100 deaths in the ongoing outbreak, ...06/25/2022 02:56 PM![Third round of rapid test rationing plan to start July 1]()
Third round of rapid test rationing plan to start July 1The Central Epidemic Command Center (CECC) on Friday announced that the third round of the government's COVID-19 rapid test kits rationing scheme will start July 1, with each ...06/24/2022 10:12 PM
Latest
- Culture
Taiwan barista comes third at World Latte Art Championship
06/26/2022 09:19 PM - Politics
- Sports
Taiwan wins recurve women's team gold at Archery World Cup
06/26/2022 07:57 PM - Politics
Vice President's herniated disk surgery successful: Presidential Office
06/26/2022 06:49 PM - Sports
Mohammad Al Bachir Gadiaga named T1 LEAGUE rookie of the year
06/26/2022 06:27 PM